Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of Impella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020; 141:273–284.
15 115. Schrage B, Ibrahim K, Loehn T, et al. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock. Circulation. 2019; 139(10):1249–1258.
RV shock (+ reference 89 above)
1 116. Bowers TR, O’Neill WW, Grines C, et al. Effect of reperfusion on biventricular function and survival after right ventricular infarction. N Engl J Med 1998; 338: 933–940.
2 117. Berisha S, Kastrati A, Goda A, Popa Y. Optimal value of filling pressure in the right side of the heart in acute right ventricular infarction. Br Heart J 1990; 63: 98–102.
3 118. Price LC, Wort SJ, Finney SJ, et al. Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for manage- ment: a systematic literature review. Crit Care 2010; 14: R169.
4 119. Haddad F, Doyle R, Murphy D, et al. Right ventricular dysfunction in cardiovascular disease, part II. Pathophysiology, clinical importance and management of right ventricular failure. Circulation 2008; 117: 1717–31.
5 120. Inglessis I, Shin JT, Lepore JT, et al. Hemodynamic effects of inhaled nitric oxide in right ventricular myocardial infarction and cardiogenic shock. J Am Coll Cardiol 2004; 44: 793–8.
Mechanical complications
1 121. Thompson CR, Buller CE, Sleeper LA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36 (3 Suppl A): 1104–9. Problem: this registry does not distinguish severe MR due to tethering from severe MR due to papillary muscle rupture.
2 122. Menon V, Webb JG, Hillis LD, et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK trial registry. J Am Coll Cardiol 2000; 36: 1110–16.
3 123. Moreno R, Lopez-Sendon J, Garcia E, et al. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002; 39: 598–603.
4 124. Lopez-Sendon J, Gonzalez A, Lopez de Sa E, et al. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction (sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria). J Am Coll Cardiol 1992; 19: 1145–53.
5 125. Slater J, Brown RJ, Antonelli TA, et al. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. J Am Coll Cardiol 2000; 36: 1117–22.
6 126. Honan MB, Harrell FE, Reimer KA, et al. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990; 16: 359–67. Early thrombolysis reduces cardiac rupture, late thrombolysis increases it.
7 127. Bueno H, Martínez-Sellés M, Pérez-David E, López-Palop R. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction. Eur Heart J 2005; 26: 1705–11. Thrombolysis increases cardiac rupture in the elderly.
8 128. Heuser RR, Maddoux GL, Goss JE, et al.; Coronary angioplasty for acute mitral regurgitation due to myocardial infarction. A nonsurgical treatment preserving mitral valve integrity. Ann Intern Med 1987; 107: 852–5. Three cases of acute ischemic dynamic MR that resolved with angioplasty.
9 129. Shawl F.A, Forman M.B, Punja S, Goldbaum T.S; Emergent coronary angioplasty in the treatment of acute ischemic mitral regurgitation. long- term results in five cases. J Am Coll Cardiol 1989; 14: 986–91.
10 130. Le Feuvre C, Metzger J.P, Lachurie M.L, Georges J.L, Baubion N, Vacheron A; Treatment of severe mitral regurgitation caused by ischemic papillary muscle dysfunction. indications for coronary angioplasty. Am Heart J 1992; 123: 860–5.
11 131. Chockalingam A, Tejwani L, Aggarwal K, Dellsperger KC. Dynamic left ventricular outflow tract obstruction in acute myocardial infarction with shock: cause, effect, and coincidence. Circulation 2007; 116: e110–13.
Arrhythmias
VF
1 132. Tunstall-Pedoe H, KuulasmaaK, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization MONICA registration project: registration procedures, event rates and case fatality rates in 30 populations from 21 countries in 4 continents. Circulation 1994; 90: 583–612.
2 133. Norris RM, on behalf of the United Kingdom Heart Attack Study Collaborative Group. Fatality outside hospital from acute coronary events in three British health districts. BMJ 1998; 316: 1065–70.
3 134. Sayer JW, Archbold RA, Wilkinson P, et al. Prognostic implications of ventricular fibrillation in acute myocardial infarction: new strategies required for further mortality reduction. Heart 2000; 84: 258–61.
4 135. Newby KH, Thompson T, Stebbins A, et al. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. Circulation 1998; 98: 2567–73. Data from GUSTO-1.
5 136. Volpi A, Cavalli A, Santoro L, Negri E. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction--results of the GISSI-2 database. Am J Cardiol 1998; 82: 265–71.
6 137. Tofler GH, Stone PH, Muller JE, et al. Prognosis after cardiac arrest due to ventricular tachycardia or ventricular fibrillation associated with acute myocar- dial infarction (the MILIS study). Am J Cardiol 1987; 60: 755–61.
7 138. Mehta RH, Yu J, Piccini JP, et al. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI trial). Am J Cardiol 2012; 109: 805–12.
8 139. Mehta RH, Starr AZ, Lopes RD, et al.; APEX AMI Investigators. Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA 2009; 301: 1779–89. VT/VF post-PCI: VT/VF that occurs during or after primary PCI is not associated with any long-term increase in mortality (APEX, HORIZONS), but increase in short-term mortality (APEX).
VT
1 140 Wolfe CL, Nibley C, Bhandari A, et al. Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 1991; 84: 1543–51.
2 141. Eldar M, Sievner Z, Goldbourt U, et al. Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. Ann Intern Med 1992; 117: 31–6.
3 142. Mont L, Cinca J, Blanch P, et al. Predisposing factors and prognostic value of sustained monomorphic ventricular tachycardia in the early phase of acute myocardial infarction. J Am Coll Cardiol 1996; 28: 1670–6.
4 143. Hatzinikolaou-Kotsakou E, Tziakas D, Hotidis A, et al. Could sustained monomorphic ventricular tachycardia in the early phase of a prime acute myocar- dial infarction affect patient outcome? J Electrocardiol 2007; 40: 72–7.
5 144. Vaitkus PT, Kindwall KE, Marchlinski FE, et al. Differences in electrophysiological substrate in patients with coronary artery disease and cardiac arrest or ventricular tachycardia. Insights from endocardial mapping and signal-averaged electrocardiography. Circulation 1991; 84: 672–8.
6 145. Scirica BM, Braunwald E, Belardinelli L, et al. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: observations from MERLIN-TIMI 36 randomized controlled trial. Circulation 2010; 122: 455–62.
AF
1 146.